Not finding it? Sign in to also search OpenAlex live.
-
Persistent transcriptional changes in cardiac adaptive immune cells following myocardial infarction: New evidence from the re-analysis of publicly available single cell and nuclei RNA-sequencing data sets2024 Journal of Molecular and Cellular Cardiology article Medicine Cardiac Fibrosis and Remodeling Open access
Natasha de Winter, Jiahui Ji, Amalia Sintou, Elvira Forte, Michael Man-Kit Lee, Michela Noseda, +8 more
12citations -
Cross-reactivity of IgM anti-modified protein antibodies in rheumatoid arthritis despite limited mutational load2021 Arthritis Research & Therapy article Medicine Rheumatoid Arthritis Research and Therapies Open access
Sanne Reijm, Theresa Kissel, Gerrie Stoeken‐Rijsbergen, Linda M. Slot, Corrie M. Wortel, Hugo J. van Dooren, +11 more
23citations -
Effects on Survival of Non-Myeloablative Chemoimmunotherapy Compared to High-Dose Chemotherapy Followed By Autologous Stem Cell Transplantation (HDC-ASCT) As Consolidation Therapy in Patients with Primary CNS Lymphoma - Results of an International Randomized Phase III Trial (MATRix/IELSG43)
Gerald Illerhaus, Andrés J.M. Ferreri, Mascha Binder, Peter Borchmann, Justin Hasenkamp, Stephan Stilgenbauer, +43 more
44citations -
Therapeutic drug monitoring guided dosing versus standard dosing of alectinib in advanced ALK positive non-small cell lung cancer patients: Study protocol for an international, multicenter phase IV randomized controlled trial (ADAPT ALEC)
Marinda Meertens, M Benthe Muntinghe-Wagenaar, Barend J. Sikkema, Marta López‐Yurda, Valesca P. Retèl, Marthe S. Paats, +16 more
12citations -
Characterization of T cell responses to co-administered hookworm vaccine candidates Na-GST-1 and Na-APR-1 in healthy adults in Gabon2021 PLoS neglected tropical diseases article Immunology and Microbiology Parasites and Host Interactions Open access
Yoanne D. Mouwenda, Madeleine Eunice Betouke Ongwe, Friederike Sonnet, Koen A. Stam, Lucja A. Labuda, Sophie De Vries, +14 more
13citations -
S182: ORAL IPTACOPAN MONOTHERAPY INCREASES PAROXYSMAL NOCTURNAL HEMOGLOBINURIA (PNH) RED BLOOD CELL CLONE SIZE VIA CONTROL OF INTRA- AND EXTRAVASCULAR HEMOLYSIS IN ANTI-C5-TREATED PNH PATIENTS WITH ANEMIA
Antonio Maria Risitano, Alexander Röth, Austin Gladston Kulasekararaj, Phillip Scheinberg, Yutaka Ueda, Eros Di Bona, +28 more
2citations -
A mouse model that is immunologically tolerant to reporter and modifier proteins2020 Communications Biology article Immunology and Microbiology T-cell and B-cell Immunology Open access
Kaspar Bresser, Feline E. Dijkgraaf, Colin E.J. Pritchard, Ivo Johan Huijbers, Ji‐Ying Song, Jan Rohr, +2 more
21citations -
Three decades of solid oxide fuel cell research: trends, challenges & future directions2026 Journal of Solid State Electrochemistry article Materials Science Advancements in Solid Oxide Fuel Cells Open access
Osaze Omoregbe, Abarasi Hart, Ifeanyichukwu Daniel Unachukwu, Ebuwa I. Osagie, Samuel Emebu, Elimian Ehiaghe, +1 more
3citations -
Activated CD4+ T Cells and Highly Differentiated Alloreactive CD4+ T Cells Distinguish Operationally Tolerant Liver Transplantation Recipients2021 Liver Transplantation article Immunology and Microbiology T-cell and B-cell Immunology Open access
Aafke A. Duizendstra, Robert Jacobus de Knegt, Shanta Mancham, Mariska Klepper, Dave L. Roelen, Simone H. Brand‐Schaaf, +8 more
12citations -
Oral Monotherapy with Iptacopan, a Proximal Complement Inhibitor of Factor B, Has Superior Efficacy to Intravenous Terminal Complement Inhibition with Standard of Care Eculizumab or Ravulizumab and Favorable Safety in Patients with Paroxysmal Nocturnal Hemoglobinuria and Residual Anemia: Results from the Randomized, Active-Comparator-Controlled, Open-Label, Multicenter, Phase III Apply-PNH Study
Régis Peffault de Latour, Alexander Roeth, Austin Gladston Kulasekararaj, Phillip Scheinberg, Yasutaka Ueda, Carlos M. de Castro, +15 more
23citations -
Safety, Tolerability, Pharmacokinetics (PK) and Preliminary Antitumor Activity of the Cyclin-Dependent Kinase-9 (CDK9) Inhibitor AZD4573 in Relapsed/Refractory Hematological Malignancies: A Phase 1 First-in-Human Study
Tim H. Brümmendorf, Patrick G. Medd, Raphael Koch, Stephan Stilgenbauer, Shringi Sharma, Yun He, +4 more
8citations -
Tub-010, a Novel Antibody-Drug-Conjugate with Reduced Nonspecific Toxicity Profile Based on Tub-Tag Technology Widens the Therapeutic Window for the Treatment of CD30+ Malignancies
Marcus Gerlach, Saskia Schmitt, Philipp Cyprys, Marc‐André Kasper, Isabelle Mai, Maarten H. Vermeer, +5 more
3citations -
Neoantigen-specific cytotoxic Tr1 CD4 T cells suppress cancer immunotherapy2024 Nature article Immunology and Microbiology Immunotherapy and Immune Responses Open access cited by 1 patent
Hussein Sultan, Yoshiko Takeuchi, Jeffrey P. Ward, Naveen Sharma, Tiantian Liu, Vladimir Sukhov, +21 more
103citations -
Identification of biomarkers for glycaemic deterioration in type 2 diabetes2023 Nature Communications article Biochemistry, Genetics and Molecular Biology Metabolomics and Mass Spectrometry Studies Open access
Roderick C. Slieker, Louise A. Donnelly, Elina Akalestou, Livia López–Noriega, Rana Melhem, Aysim Güneş, +60 more
48citations